Early cancer drug trial halted after testing in just 3 patients
Disease control
Terminated
This was an early-stage study to check the safety and find a safe dose of an experimental oral drug called INCB086550 for Japanese patients with advanced solid tumors that had stopped responding to standard treatments. The study was terminated early and only enrolled three partic…
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC